Sign In
Stock Market
US Election, Q2 Earnings, Fed Meeting, and 5 Other Factors Likely to Influence Stock Markets This Week
News Capsules
Lupin Enters into Deal with Takeda to Commercialise Vonoprazan
Pharma
Lupin receives tentative USFDAapproval for three extended-release tablets
Industry
Lupin recalls 51k bottles of generic antibiotic
Lupin completes acquisition of two brands from Sanofi in Europe and Canada
Lupin gets ISO 14001 and ISO 45001 certification for all its Indian units
Jeffrey Kindler, Alfonso Zulueta join Lupin Board as Independent Directors
Technology
Cipla, Glenmark recall drugs in US
Lupin's Aurangabad facility earns U.S. FDA approval
Lupin gets USFDA nod for seizures generic medication
Corporate
Lupin's stock gains on USFDA approval for hypertension medication
Lupin introduces generic product in US market
